Market Overview:
The global appendiceal cancer treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of appendiceal cancer, rising awareness about the disease, and technological advancements in the field of cancer treatment. Based on type, the market is segmented into medicine, surgery, and other treatments. The surgery segment accounted for the largest share of the global appendiceal cancer treatment market in 2017 and is projected to grow at a CAGR of 7.8% from 2018 to 2030. This growth can be attributed to increasing use of minimally invasive surgeries for treating appendiceal cancers. Based on application, the market is segmented into hospitals, clinics, cancer research institutes, and other applications such as home care settings and military hospitals/clinics etc.).
Product Definition:
Appendiceal cancer is a rare type of cancer that starts in the appendix. The appendix is a small, finger-like structure that extends from the large intestine. Treatment for appendiceal cancer may include surgery to remove the appendix and surrounding tissues, chemotherapy, radiation therapy, or a combination of these treatments.
Medicine:
Appendiceal cancer is a malignant tumor that develops in the appendiceum, the part of the innermost organ in the human body. The main function of this organ is to cleanse and protect from infections around it. Appendicular or perianal tumors are rare cancers that develop from epithelial cells (cells responsible for skin texture).
Surgery:
Appendiceal cancer is a malignant tumor that develops in the appendiceum or tail of the kidney. Appendiceal carcinoma can be primary ( originating from the ureter, bladder, or bowel) or secondary ( derived from other parts of the body). The most common site for an appendicular malignancy is within one inch of where it exits out of the body on to the skin - this is called apposition melanoma.
Application Insights:
The hospital application segment dominated the global appendiceal cancer treatment market in 2017. The hospital-based clinics provide affordable and convenient access to high quality healthcare services for patients who have been diagnosed with cancer. Furthermore, hospitals are the most preferred locations for medical oncology procedures due to advanced healthcare facilities and highly skilled staffs. However, rising prevalence of chronic diseases such as heart diseases, respiratory disorders and diabetes is expected to drive demand in other applications over the forecast period.
Appendiceal tumors are rare; they comprise a low metastatic potential which makes them suitable for curative therapy especially at early stages when treated by primary surgical resection or ablation techniques followed by chemotherapy or radiation therapy after surgery.
Regional Analysis:
North America dominated the global appendiceal cancer treatment market in 2017. This can be attributed to the high incidence rate of this disease, increasing adoption of innovative techniques and treatments, availability of highly skilled physicians, and supportive government initiatives. In addition, a rise in consumer awareness is also expected to drive growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare infrastructure coupled with rising patient awareness levels pertaining to available treatment options for various cancers including appendiceal cancer. Moreover, improvements in reimbursement policies by regulatory authorities such as Ministry Of Health And Family Welfare (MoHFW) & Department Of Pharmaceuticals And Medical Devices (DoPD), Government Of India are anticipated to further boost regional growth over the next eight years.
Growth Factors:
- Increasing incidence of appendiceal cancer
- Growing awareness about the disease and its treatment options
- Rising demand for better and more effective treatments for appendiceal cancer
- Technological advancements in the field of cancer treatment
- Growing focus on research and development activities to find new and better ways to treat appendiceal cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Appendiceal Cancer Treatment Market Research Report
By Type
Medicine, Surgery, Other,
By Application
Hospital, Clinic, Cancer Research Institute, Other,
By Companies
Amgen, Pfizer, Eli Lilly and Company, AbbVie, Bristol-Myers Squibb, Roche Holding, Becton Dickinson, Novartis, General Electric, AstraZeneca, Boehringer Ingelheim International, Teva Pharmaceutical Industries, Sanofi, Bayer,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Appendiceal Cancer Treatment Market Report Segments:
The global Appendiceal Cancer Treatment market is segmented on the basis of:
Types
Medicine, Surgery, Other,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Cancer Research Institute, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Pfizer
- Eli Lilly and Company
- AbbVie
- Bristol-Myers Squibb
- Roche Holding
- Becton Dickinson
- Novartis
- General Electric
- AstraZeneca
- Boehringer Ingelheim International
- Teva Pharmaceutical Industries
- Sanofi
- Bayer
Highlights of The Appendiceal Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medicine
- Surgery
- Other
- By Application:
- Hospital
- Clinic
- Cancer Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Appendiceal Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Appendiceal cancer is a type of cancer that starts in the appendix. It is usually treated with surgery and radiation therapy.
Some of the major players in the appendiceal cancer treatment market are Amgen, Pfizer, Eli Lilly and Company, AbbVie, Bristol-Myers Squibb, Roche Holding, Becton Dickinson, Novartis, General Electric, AstraZeneca, Boehringer Ingelheim International, Teva Pharmaceutical Industries, Sanofi, Bayer.
The appendiceal cancer treatment market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Appendiceal Cancer Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Appendiceal Cancer Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Appendiceal Cancer Treatment Market - Supply Chain
4.5. Global Appendiceal Cancer Treatment Market Forecast
4.5.1. Appendiceal Cancer Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Appendiceal Cancer Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Appendiceal Cancer Treatment Market Absolute $ Opportunity
5. Global Appendiceal Cancer Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
5.3.1. Medicine
5.3.2. Surgery
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Appendiceal Cancer Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Cancer Research Institute
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Appendiceal Cancer Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Appendiceal Cancer Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Appendiceal Cancer Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Appendiceal Cancer Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Appendiceal Cancer Treatment Demand Share Forecast, 2019-2026
9. North America Appendiceal Cancer Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Appendiceal Cancer Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Cancer Research Institute
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
9.7.1. Medicine
9.7.2. Surgery
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Appendiceal Cancer Treatment Demand Share Forecast, 2019-2026
10. Latin America Appendiceal Cancer Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Appendiceal Cancer Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Cancer Research Institute
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
10.7.1. Medicine
10.7.2. Surgery
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Appendiceal Cancer Treatment Demand Share Forecast, 2019-2026
11. Europe Appendiceal Cancer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Appendiceal Cancer Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Cancer Research Institute
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
11.7.1. Medicine
11.7.2. Surgery
11.7.3. Other
11.8. Basis Point Shre (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Appendiceal Cancer Treatment Demand Share, 2019-2026
12. Asia Pacific Appendiceal Cancer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Appendiceal Cancer Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Cancer Research Institute
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
12.7.1. Medicine
12.7.2. Surgery
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Appendiceal Cancer Treatment Demand Share, 2019-2026
13. Middle East & Africa Appendiceal Cancer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Appendiceal Cancer Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Appendiceal Cancer Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Cancer Research Institute
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Appendiceal Cancer Treatment Market Size and Volume Forecast by Type
13.7.1. Medicine
13.7.2. Surgery
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Appendiceal Cancer Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Appendiceal Cancer Treatment Market: Market Share Analysis
14.2. Appendiceal Cancer Treatment Distributors and Customers
14.3. Appendiceal Cancer Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly and Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AbbVie
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bristol-Myers Squibb
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche Holding
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Becton Dickinson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Novartis
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. General Electric
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. AstraZeneca
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Boehringer Ingelheim International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Teva Pharmaceutical Industries
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sanofi
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Bayer
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook